Kronos Bio Inc Cash Flow-to-Debt Ratio
Kronos Bio Inc cash flow-to-debt ratio. Kronos Bio Inc (KRON) has a Cash Flow-to-Debt Ratio of -0.45x as of March 2025, meaning its operating cash flow of $-12.84 Million could theoretically repay 0% of its total liabilities ($28.33 Million) in one year. See KRON free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Kronos Bio Inc (2018–2024)
Cash flow-to-debt ratio of Kronos Bio Inc from 2018 to 2024. Historical debt coverage capacity for Kronos Bio Inc across 7 annual periods. Also explore KRON net asset momentum to track the company's year-over-year net asset growth rate.
Kronos Bio Inc Cash Flow-to-Debt Ratio by Year (2018–2024)
Kronos Bio Inc cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for Kronos Bio Inc. For the full cash flow conversion analysis, see Kronos Bio Inc (KRON) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.78x | $-65.44 Million | $36.78 Million | ▼ -22.7% |
| 2023 | -1.45x | $-78.58 Million | $54.20 Million | ▲ +19.6% |
| 2022 | -1.80x | $-90.93 Million | $50.44 Million | ▲ +29.1% |
| 2021 | -2.54x | $-117.92 Million | $46.38 Million | ▼ -211.5% |
| 2020 | -0.82x | $-37.91 Million | $46.45 Million | ▼ -581.3% |
| 2019 | -0.12x | $-15.08 Million | $125.89 Million | ▲ +63.0% |
| 2018 | -0.32x | $-6.44 Million | $19.91 Million | — |